Hypertrophic Cardiomyopathy Webinars


Learn more about HCM so you are better able to discuss its impact with your patients through this free webinar series. Be sure to check here for live webinar registration opportunities as dates are confirmed.

Sudden Cardiac Death Prevention in HCM: Where Do We Stand in 2021?

Futuristic graphic representation of the human heart and its vessel system

Recorded webinar available July 31st

Presenters: Martin S. Maron, MD; Marye Gleva, MD
Moderator: James E. Udelson, MD, FAHA

Some people with HCM are at increased risk for developing atrial fibrillation, heart failure, suffering from stroke and even sudden cardiac death (SCD). Patients who suffer from arrhythmias associated with HCM may require implantable cardioverter-defibrillator devices to reduce their risk of SCD. Join Drs. Maron, Gleva, and Udelson as they discuss risk stratification strategies, device selection, and the role of shared decision-making in the prevention of SCD.

Martin S. Maron, MD

Martin S. Maron, MD
Director of the Hypertrophic Cardiomyopathy Center and the Co-Director of the Cardiac CT and MRI program at Tufts Medical Center and Associate Professor at Tufts University School of Medicine

Marye Gleva

Marye Gleva, MD
Professor of Medicine, Washington University School of Medicine in St. Louis

Dr. James E. Udelson, MD, FAHA
Chief, Division of Cardiology,
Tufts Medical Center

Enduring Webinars

Imaging for the Diagnosis and Management of Hypertrophic Cardiomyopathy

Presenters: Theodore Abraham, MD; Ethan Rowin, MD
Moderator: James E. Udelson, MD, FAHA

Hypertrophic cardiomyopathy is the most common form of genetic heart disease and can affect people of any age, yet it often goes undiagnosed. Diagnosis is typically done by echocardiogram to assess the thickness of the heart muscle and observe blood flow in and out of the heart.

Viewers will learn about the role of imaging in the diagnosis and treatment of patients with HCM.

Theodore Abraham, MDTheodore Abraham, MD
Director, HCM Center of Excellence
UCSF

 

 

Ethan Rowin, MDEthan Rowin, MD
Co-Director, HCM Institute
Tufts Medical Center

 

 

James E. Udelson, MD, FAHAJames E. Udelson, MD, FAHA
Chief, Division of Cardiology
Tufts Medical Center

 

 

Hypertrophic Cardiomyopathy: An Introduction and Overview

Presenters: Dr. Sharon Cresci, Dr. Robert Fraser
Moderator: Dr. James Udelson

Summary: Hypertrophic cardiomyopathy or HCM is a primary myocardial disorder defined by left ventricular (LV) hypertrophy that cannot be explained by another cardiac or systemic disease. Some people with HCM experience symptoms such as fatigue, fainting, shortness of breath, chest pain or palpitations. Others with HCM do not experience any symptoms. Listen to experts as they explore the HCM symptoms, epidemiology, pathophysiology and the burden of the disease on patients and families.

Learn more about HCM in this free webinar so you are better able to discuss its impact with your patients.

Robert J. Fraser, MD 
Minneapolis Heart Institute®
Abbot Northwestern Hospital & Hennepin County Medical Center

 

 

Sharon Cresci, MD, FAHA, FACC, FASE
Washington University, Cardiovascular Division
Associate Professor of Medicine, Associate Professor of Genetics

 

 

James E. Udelson, MD, FAHA
Chief, Division of Cardiology
Tufts Medical Center



Clinical Implications of Genetic Testing in Hypertrophic Cardiomyopathy

Presenters: Dr. Anjali Owens, Dr. Sharon Cresci
Moderator: Dr. James Udelson

Summary: It is estimated that 1 in every 500 adults living in the U.S. have HCM, but a large percentage of patients are undiagnosed. Which of your patients is undiagnosed? Hypertrophic Cardiomyopathy (HCM) is the most common form of genetic heart disease and can affect people of any age. HCM can be a debilitating and life-changing disease. People with HCM are often forced to make lifestyle changes, such as limiting their activity, to accommodate their disease. Sometimes this accommodation might not even be noticed by the patient themselves meaning careful questioning of symptoms and changes in activity are critical.

Learn more about HCM in this free webinar so you are better able to discuss its impact with your patients.

Anjali Tiku Owens, MD
Assistant Professor of Medicine
University of Pennsylvania

 

 

Sharon Cresci, MD, FAHA, FACC, FASE
Washington University, Cardiovascular Division
Associate Professor of Medicine, Associate Professor of Genetics

 

 

James E. Udelson, MD, FAHA
Chief, Division of Cardiology
Tufts Medical Center

 

 

American Heart Association's Hypertrophic Cardiomyopathy Initiative is sponsored by Bristol Myers Squibb.